Your account is not claimed yet. You can sign up with ORCID to claim your account.

Simon P Fletcher

Years Active: 2020-2021
Publications (10 Years): 2

Gilead Sciences

University of Cambridge (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Gilead Sciences

United States

Executive Director

Education History

University of Cambridge

United Kingdom

PHD

Publications

Oliver E Amin, Emily J Colbeck, Stephane Daffis, Shahzada Khan, Dhivya Ramakrishnan, Divya Pattabiraman, Ruth Chu, Holly Micolochick Steuer, Sophie Lehar, Leanne Peiser, Adam Palazzo, Christian Frey, Jessica Davies, Hassan Javanbakht, William M C Rosenberg, Simon P Fletcher, Mala K Maini, Laura J Pallett
Therapeutic Potential of TLR8 Agonist GS-9688 (Selgantolimod) in Chronic Hepatitis B: Remodeling of Antiviral and Regulatory Mediators. Hepatology (Baltimore, Md.) 74 (1) (2021)
Stephane Daffis, Scott Balsitis, Jason Chamberlain, Jim Zheng, Rex Santos, William Rowe, Dhivya Ramakrishnan, Divya Pattabiraman, Sandra Spurlock, Ruth Chu, Don Kang, Michael Mish, Ricardo Ramirez, Li Li, Bei Li, Sarina Ma, Magdeleine Hung, Christian Voitenleitner, Changsuek Yon, Manasa Suresh, Stephan Menne, Paul Cote, William E Delaney, Richard Mackman, Simon P Fletcher
Toll-Like Receptor 8 Agonist GS-9688 Induces Sustained Efficacy in the Woodchuck Model of Chronic Hepatitis B. Hepatology (Baltimore, Md.) 73 (1) (2020)

Simon P Fletcher.css-eqlu8i{font-size:small;padding-left:4px;}